| 000 | 01396 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511185541.0 | ||
| 264 | 0 | _c19930205 | |
| 008 | 199302s 0 0 eng d | ||
| 022 | _a0268-1161 | ||
| 024 | 7 |
_a10.1093/oxfordjournals.humrep.a137830 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJackson, A E | |
| 245 | 0 | 0 |
_aExposure to LHRH agonists in early pregnancy following the commencement of mid-luteal buserelin for IVF stimulation. _h[electronic resource] |
| 260 |
_bHuman reproduction (Oxford, England) _cOct 1992 |
||
| 300 |
_a1222-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAbortion, Spontaneous _xchemically induced |
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBuserelin _xadverse effects |
| 650 | 0 | 4 |
_aChorionic Gonadotropin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFertilization in Vitro |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLuteal Phase |
| 650 | 0 | 4 | _aOvulation Induction |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 | _aPregnancy Trimester, First |
| 650 | 0 | 4 |
_aProgesterone _xtherapeutic use |
| 700 | 1 | _aCurtis, P | |
| 700 | 1 | _aAmso, N | |
| 700 | 1 | _aShaw, R W | |
| 773 | 0 |
_tHuman reproduction (Oxford, England) _gvol. 7 _gno. 9 _gp. 1222-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/oxfordjournals.humrep.a137830 _zAvailable from publisher's website |
| 999 |
_c1485484 _d1485484 |
||